Overview

Staccato Loxapine in Migraine (Out Patient)

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting.

Phase:

Phase 2

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Treatments:

Loxapine